Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

14.05.2024 / 11:10 CET/CEST
The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name
Title:
First name: Thomas
Last name(s): Milz

2. Reason for the notification

a) Position / status
Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name
APONTIS PHARMA AG

b) LEI
894500ETO1J6MR8PDF91 

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code
Type: Share
ISIN: DE000A3CMGM5

b) Nature of the transaction
Acquisition

c) Price(s) and volume(s)
Price(s) Volume(s)
8.96 EUR 8960.00 EUR

d) Aggregated information
Price Aggregated volume
8.9600 EUR 8960.0000 EUR

e) Date of the transaction
13/05/2024; UTC+2

f) Place of the transaction
Name: Tradegate
MIC: TGAT


14.05.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com

Language: English
Company: APONTIS PHARMA AG
Alfred-Nobel-Str. 10
40789 Monheim
Germany
Internet:https://apontis-pharma.de/

 
End of News EQS News Service

91497  14.05.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1902633&application_name=news&site_id=zonebourse_com~~~71435185-72e2-4ff3-98c0-1866a1714c4a